LuPIN trial final results in JNM. LuPSMA-617 + NOX66 in 56pts with met CRPC post chemo safe and effective with median OS 19.7mths. Prognostic value of baseline PSMA and FDG PET evaluated: high PSMA tumour volume most strongly assoc with poor OS @drlouiseemmett@AnthonyMJoshua
Clinical practice guidelines for acute otitis media in children: a systematic review and appraisal of European national guidelines https://t.co/FXo6y4Uwht #paediatrics#childhealth#otitismedia
This is Susan.
She is one of the few people I now have contact with. With great care, she collects blood from me before each treatment. Susan usually spends Easter with her family, but to protect me and other patients, she can't do that this year.
#coronavirusaus#EasterAtHome
Antibiotics negatively impact on OS and PFS in cancer patients treated with immunotherapy- but timing of exposure is key. Check out our meta-analysis published today in Cancer, Immunology, Immunotherapy https://t.co/UCBlAHeCUa
@chin_venessa@AdnanNagrial @BertrandRouty
Great talk from A/Prof Nielka van Erp about oncology drug interactions at #DISCO2019. 💉💊 Tricky interactive cases and a nifty app: https://t.co/cTURiKLokG